Now showing items 1-1 of 1
Antitumoral, mutagenic and (anti)estrogenic activities of tingenone and pristimerin
(Revista Brasileira de Farmacognosia-brazilian Journal of Pharmacognosy, 2011-11-01) [Artigo]
Cancer constitutes the second main mortality cause in the world, after cardiovascular diseases. In spite of the progresses in the chemotherapeutics treatments, many patients fail chemotherapy, mainly because of side effects ...